2019
DOI: 10.1016/j.jddst.2019.101311
|View full text |Cite
|
Sign up to set email alerts
|

Facile preparation of pH-responsive k-Carrageenan/tramadol loaded UiO-66 bio-nanocomposite hydrogel beads as a nontoxic oral delivery vehicle

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 43 publications
(20 citation statements)
references
References 62 publications
0
20
0
Order By: Relevance
“…For both cell lines, no significant cytotoxic effect was observed [ 31 ]. Moreover, pH-responsive k-Carrageenan/tramadol loaded UiO-66 bio-nanocomposite hydrogel beads proposed by Javanbakht et al did not reduce the viability of human colon cells [ 32 ]. Another safe and effective carrier was described by Nia et al The fabricated pH-sensitive carboxymethylcellulose-based bio-nanocomposite hydrogel beads, designed as a controlled amoxicillin nanocarrier for colonic bacterial infection treatment, did not reveal cytotoxicity to human umbilical vein endothelial cells (HUVECs) [ 33 ].…”
Section: Resultsmentioning
confidence: 99%
“…For both cell lines, no significant cytotoxic effect was observed [ 31 ]. Moreover, pH-responsive k-Carrageenan/tramadol loaded UiO-66 bio-nanocomposite hydrogel beads proposed by Javanbakht et al did not reduce the viability of human colon cells [ 32 ]. Another safe and effective carrier was described by Nia et al The fabricated pH-sensitive carboxymethylcellulose-based bio-nanocomposite hydrogel beads, designed as a controlled amoxicillin nanocarrier for colonic bacterial infection treatment, did not reveal cytotoxicity to human umbilical vein endothelial cells (HUVECs) [ 33 ].…”
Section: Resultsmentioning
confidence: 99%
“…Based on our previous studies on biomedical platforms, the objective of the present work is to synthesize the pH-responsive photoluminescent nanocarrier using a more efficient drug imprinting strategy via an innovative combination of PHEMA with GQDs. We present the development of PLMIPs for the imprinting of an anticancer DOX drug that is used as a typical anticancer drug in chemotherapy.…”
Section: Introductionmentioning
confidence: 99%
“…Until now, different systems have been prepared as DDSs to deliver the wanted drug molecules to the special site of the body. Among them, today's, nanotechnology‐based DDSs have received much more consideration because of their sustainability, the potential for improving drug solubility, stimuli‐sensitive drug release pattern, circulation time, reducing the drug resistance, and low side effects 96–100 . CA is one of the nontoxic biomaterials that is commonly used in the synthesis of various NPs or their modification.…”
Section: Ca‐based Ddssmentioning
confidence: 99%
“…Among them, today's, nanotechnology-based DDSs have received much more consideration because of their sustainability, the potential for improving drug solubility, stimuli-sensitive drug release pattern, circulation time, reducing the drug resistance, and low side effects. [96][97][98][99][100] CA is one of the nontoxic biomaterials that is commonly used in the synthesis of various NPs or their modification. This biomaterial plays several beneficial roles in the nanoscience which prevention from the NPs agglomeration, increasing the stability in the biological medium, cosurfactant, template, increasing the drug loading ability through the introduction of the new carboxylic groups on the structure, capping agent, reducing agent in the NPs synthesis step, as well as, ameliorate biocompatibility are some of them.…”
Section: Ca-based Nanoplatformsmentioning
confidence: 99%